Last reviewed · How we verify

NCT04505644

Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean Section

Status unknown NA Last updated 11 August 2020
What this trial tests

NA trial testing lidocaine patch in Cesarean Section Complications in 180 participants. Status unknown.

Timeline
1 September 2020
Primary endpoint
30 March 2021
30 May 2021

Quick facts

Lead sponsorAswan University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment180
Start date1 September 2020
Primary completion30 March 2021
Estimated completion30 May 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Aswan University Hospital

Who can join

Adults 18 to 45, female only, with Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the efficacy of lidocaine patch applied around wound in reduction of postoperative pain and illus compared to intravenous lidocaine infusion and placebo after cesarean section.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of lidocaine patch

Trials testing the same drug.

Other recruiting trials for Cesarean Section Complications

Currently open trials in the same condition.

Other Aswan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04505644.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing